McKinsey & Company to pay $650 million for role in opioid crisis
December 14, 2024
McKinsey and Company has agreed to pay $650 million to settle federal civil and criminal probes into alleged wrongdoing linked to “turbocharging” opioid sales on behalf of Purdue Pharma.
Fabrice Coffrini/AFP via Getty Images